SCHEMBL3729288

SCHEMBL3729288

COc1c(C)c(C=C(C)C(=O)NCCCCCCN)c(OC)c(OC)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.42
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DNM1 Q05193 3/20 0.34
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
SLC6A5 Q9Y345 2/20 0.33
HTR1A P08908 2/20 0.32
HTR2C P28335 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTR2A P28223 1/20 0.32
SLC6A4 P31645 1/20 0.32
HTR7 P34969 1/20 0.32
HTR6 P50406 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
SIRT6 Q8N6T7 1/20 0.32
SIRT1 Q96EB6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729283 1.00 PAOX (0.42) PAOXMEN1KMT2ADNM1GNAI3
SCHEMBL3752037 0.83 TDP1 (0.46) MEN1KMT2AGAA
SCHEMBL13049571 0.82 APEX1 (0.47) PAOXGNAI3GNAO1GNAI1SLC6A5
SCHEMBL10707223 0.71 PAOX (0.62) PAOXGNAI3GNAO1GNAI1SLC6A5
SCHEMBL3752882 0.70 APEX1 (0.45)
SCHEMBL3752883 0.70 APEX1 (0.45)
SCHEMBL23196778 0.70 PAOX (0.59) PAOXMEN1KMT2AGNAI3GNAO1
SCHEMBL29576044 0.70 PAOX (0.59) PAOXMEN1KMT2AGNAI3GNAO1
Hydrochloric Acid SCHEMBL29277251 0.68 PAOX (0.57) PAOXMEN1KMT2AGNAI3GNAO1
Hydrochloric Acid SCHEMBL30177523 0.68 PAOX (0.57) PAOXMEN1KMT2AGNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed
EP-2203161-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Indiana University Research and Technology Corporation (US) 2010-07-07 EP disclosed
WO-2009042544-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 PAOX 1091/4885MEN1 2751/4885KMT2A 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.